{
  "meta": {
    "timestamp": "2025-01-06T10:29:21.633133",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Doximity Inc",
      "symbol": "DOCS",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Legal and regulatory scrutiny over potential breaches of fiduciary duties and misleading financial statements",
            "Revenue concentration in pharmaceutical advertising, making it vulnerable to regulatory changes",
            "Increasing competition from other healthcare technology platforms and telehealth providers",
            "Data privacy and security concerns due to handling sensitive healthcare information"
          ],
          "controversies": [
            "Class action lawsuits alleging misleading statements about financial health and growth prospects",
            "Report by Jehoshaphat Research claiming declining underlying sales masked by accelerated revenue recognition"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Allegations of misleading shareholders about profitability and growth sustainability",
            "Potential reputational damage from shareholder lawsuits"
          ],
          "governance_issues": [
            "Investigation into potential breaches of fiduciary duties by the board of directors",
            "Concerns over financial transparency and revenue recognition practices"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Doximity Inc (DOCS) Faces Shareholder Investigation Amid ... - GuruFocus",
              "snippet": "On December 19, 2024, Bragar Eagel & Squire, P.C., a prominent shareholder rights law firm, announced an investigation into Doximity Inc (DOCS, Financial) following a class action complaint filed on April 17, 2024.The investigation focuses on potential breaches of fiduciary duties by Doximity's board of directors during the class period from February 9, 2022, to April 1, 2024.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713545+00:00",
              "published_date": null,
              "source_hash": "c4400117b5242f3f6349d6ecf4f40c76"
            },
            {
              "url": "",
              "title": "Doximity at Crossroads: An In-Depth Examination of the ... - CSIMarket",
              "snippet": "Here, we delve into the intricacies of this legal action, its potential repercussions for the company, and the broader implications for the healthcare technology sector.*Understanding Doximity*Doximity, often dubbed the LinkedIn for Doctors, boasts an expansive network for healthcare professionals to connect, collaborate, and stay informed.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713525+00:00",
              "published_date": null,
              "source_hash": "a4a1d6fff9c67123c04bad3f49010cd6"
            },
            {
              "url": "",
              "title": "Doximity, Inc. (NYSE: DOCS) - Kahn Swick & Foti, LLC",
              "snippet": "Doximity, Inc. (NYSE: DOCS) Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\"KSF\"), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). ... This privacy notice applies to www.ksfcounsel.com and all other websites on the World Wide Web ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:51.497311+00:00",
              "published_date": null,
              "source_hash": "01e40952a74ca50d07d8ab2089a2c58d"
            },
            {
              "url": "",
              "title": "Doximity, Inc. Investors Notice: Class action lawsuit filed - GlobeNewswire",
              "snippet": "Following this news, Doximity's stock price declined $1.11 per share, or more than 4%, over two trading days, from $26.91 per share on March 28, 2024, to $25.80 per share on April 2, 2024.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:51.497326+00:00",
              "published_date": null,
              "source_hash": "117e6bfb5130bd00718507b50f58939e"
            },
            {
              "url": "",
              "title": "Doximity Class Action Lawsuit: 8 Frequently Asked Questions",
              "snippet": "The Doximity class action lawsuit seeks to represent purchasers or acquirers of Doximity, Inc. (NYSE: DOCS) publicly traded securities between February 9, 2022 and April 1, 2024, inclusive (the \"Class Period\"). Captioned Kissler v. Doximity, Inc., No. 24-cv-02281 (N.D. Cal.), the Doximity lawsuit charges Doximity and certain of Doximity's top executives with violations of the Securities ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:51.497341+00:00",
              "published_date": null,
              "source_hash": "185cf34cda8f9b49cccb92a347d62f0c"
            },
            {
              "url": "",
              "title": "Investigation into Doximity, Inc.: What Long-Term Investors Need to ...",
              "snippet": "Doximity, Inc. has caught the attention of a well-known law firm, Bragar Eagel & Squire, P.C., which is currently investigating potential claims on behalf of long-term stockholders. This investigation comes as a result of a class action complaint that arose during a specified class period, primarily concerning the company's operational ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713586+00:00",
              "published_date": null,
              "source_hash": "b53cdc5bf632e33ad83570971d277d06"
            },
            {
              "url": "",
              "title": "Class Action Lawsuit Filed on Behalf of Doximity, Inc. - GlobeNewswire",
              "snippet": "ATLANTA, April 19, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Doximity, Inc. (\"Doximity\" or the \"Company\") (NYSE: DOCS). The lawsuit alleges that ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:51.497368+00:00",
              "published_date": null,
              "source_hash": "18fc21f57ce1b1d8c438ce957bc73416"
            },
            {
              "url": "",
              "title": "CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer ... - Markets Insider",
              "snippet": "CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Doximity, Inc. PRESS RELEASE Accesswire Apr. 19, 2024, 09:20 AM",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:51.497380+00:00",
              "published_date": null,
              "source_hash": "b8646b416720129ca9fe57496f405ed1"
            },
            {
              "url": "",
              "title": "Doximity, Inc. - The Rosen Law",
              "snippet": "Rosen Law Firm, a global investor rights law firm, announces a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the \"Class Period\"). A class action lawsuit has already been ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:51.497392+00:00",
              "published_date": null,
              "source_hash": "26b48a214556baa593c8359ab43db9a6"
            },
            {
              "url": "",
              "title": "INTRODUCTION TO THE DOXIMITY CLASS ACTION LAWSUIT - Medium",
              "snippet": "The Doximity class action lawsuit seeks to represent purchasers or acquirers of Doximity, Inc. (NYSE: DOCS) publicly traded securities between February 9, 2022 and April 1, 2024, inclusive (the\u2026",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:51.497405+00:00",
              "published_date": null,
              "source_hash": "b1ffda6e38ab34eb2f052baf9594c986"
            },
            {
              "url": "",
              "title": "DOXIMITY INVESTOR NOTICE: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties - DOCS",
              "snippet": "Scott+Scott is investigating whether members of Doximity's board of directors or senior management failed to manage Doximity in an acceptable manner, in breach of their fiduciary duties to Doximity, and whether Doximity and its shareholders have suffered ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:54.872861+00:00",
              "published_date": "2024-11-19T22:01:00+00:00",
              "source_hash": "e54f1425d0f3edda6ef8a68e82c7db61"
            },
            {
              "url": "",
              "title": "Why Doximity Inc. (DOCS) Skyrocketed?",
              "snippet": "We recently published a list of 10 Biggest Gainers of Last Week. In this article, we are going to take a look at where Doximity Inc. (NYSE:DOCS) stands against other biggest gainers of last week. Investors gobbled up shares of predominantly technology companies last week,",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:54.872971+00:00",
              "published_date": "2024-12-23T19:32:33+00:00",
              "source_hash": "6291f16dd03dec8eb58a5ab16a91364d"
            },
            {
              "url": "",
              "title": "Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Rating of \"Hold\" from Brokerages",
              "snippet": "Shares of Doximity, Inc. (NASDAQ:DOCS - Get Free Report) have been assigned a consensus rating of \"Hold\" from the twenty brokerages that are covering the firm, MarketBeat Ratings reports.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:54.873005+00:00",
              "published_date": "2024-12-27T00:00:00+00:00",
              "source_hash": "dd367378a7793d051d465e0133c261bc"
            },
            {
              "url": "",
              "title": "Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care",
              "snippet": "SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:54.873033+00:00",
              "published_date": "2024-12-17T08:00:00+00:00",
              "source_hash": "043fdc1bddf52542fad487b9e6041dd2"
            },
            {
              "url": "",
              "title": "Sanctuary Advisors LLC Lowers Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)",
              "snippet": "Sanctuary Advisors LLC reduced its position in Doximity, Inc. (NASDAQ:DOCS - Free Report ... a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc data privacy lawsuits",
              "retrieved_at": "2025-01-06T17:28:54.873065+00:00",
              "published_date": "2024-12-28T00:00:00+00:00",
              "source_hash": "a606d6e2736274539a5eef4f9b158bcb"
            },
            {
              "url": "",
              "title": "Decoding Doximity Inc (DOCS): A Strategic SWOT Insight - Yahoo Finance",
              "snippet": "On November 7, 2024, Doximity Inc , the leading digital platform for U.S. medical professionals, filed its 10-Q report, revealing a comprehensive overview of its financial performance and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454508+00:00",
              "published_date": null,
              "source_hash": "666aaf1ea84cd17f4358b49df330680b"
            },
            {
              "url": "",
              "title": "Doximity Announces Fiscal 2025 Second Quarter Financial Results",
              "snippet": "Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024. \"Our clinical workflow tools saw record use in Q2 with over 600,000 unique active ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454623+00:00",
              "published_date": null,
              "source_hash": "3f4a530cae3ff93039c007de8b8a9d84"
            },
            {
              "url": "",
              "title": "Doximity's SWOT analysis: stock faces growth challenges amid strong ...",
              "snippet": "In its most recent fiscal quarter, Doximity reported revenue of $126.7 million, representing a 17% year-over-year increase. ... Doximity will need to find new avenues for growth or risk falling ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454638+00:00",
              "published_date": null,
              "source_hash": "efc81505207d20f23340d0847e1f7e64"
            },
            {
              "url": "",
              "title": "Document - SEC.gov",
              "snippet": "SAN FRANCISCO, Calif., February 8, 2022-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, ... may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the impact of the COVID-19 pandemic (including the impact to our ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454648+00:00",
              "published_date": null,
              "source_hash": "8f0a158ee0020bbb344c9c3ecf1fd6f2"
            },
            {
              "url": "",
              "title": "Doximity - Doximity Announces Fourth Quarter and Fiscal Year 2023 ...",
              "snippet": "Q4 total revenues of $111.0 million, up 18% year-over-year Q4 net income margin of 28% and adjusted EBITDA margin of 44% Fiscal year 2023 total revenues of $419.1 million, up 22% year-over-year Fiscal year 2023 net income margin of 27% and adjusted EBITDA margin of 44% Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454658+00:00",
              "published_date": null,
              "source_hash": "a9b2ab6334b951379980bc6a2f6ca5b6"
            },
            {
              "url": "",
              "title": "Doximity Inc (DOCS) Q2 2025 Earnings Call Highlights: Record Revenue ...",
              "snippet": "Revenue: $137 million for Q2 fiscal 2025, 20% year-on-year growth. Adjusted EBITDA Margin: 56%, representing 41% year-on-year growth. Net Revenue Retention Rate: 116% on a trailing 12-month basis.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454667+00:00",
              "published_date": null,
              "source_hash": "ce54c4d2aa4fc5217870b0cb27b76151"
            },
            {
              "url": "",
              "title": "DOCS | Doximity Inc. Financial Statements - WSJ",
              "snippet": "Doximity Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. ... Risk & Compliance; WSJ Professional. ... Sales or Revenue: 136.83 M: Sales or Revenue Growth ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454677+00:00",
              "published_date": null,
              "source_hash": "6f728c77a2f02959caf436a158ff34ab"
            },
            {
              "url": "",
              "title": "Doximity Inc (DOCS) Q1 2025 Earnings Call Highlights: Strong Revenue ...",
              "snippet": "Revenue: $127 million for Q1 fiscal 2025, 17% year-over-year growth. Adjusted EBITDA Margin: 52%, $66 million, 18% above guidance. Net Revenue Retention Rate: 114% overall, 121% for top 20 customers.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454685+00:00",
              "published_date": null,
              "source_hash": "427069d1edb603d59296c4639399ee67"
            },
            {
              "url": "",
              "title": "Doximity: Adding Value Using AI But Faces Near-Term Risks - Seeking Alpha",
              "snippet": "Doximity's stock has experienced a significant drop in value due to downsized revenue guidance for Q2 2024. The company's revenue growth has been impacted by a decrease in net revenue retention ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454694+00:00",
              "published_date": null,
              "source_hash": "22c271b3cbccdbc87b26850b734808a0"
            },
            {
              "url": "",
              "title": "Doximity - Investor Relations",
              "snippet": "By bringing medical professionals across the nation into a single virtual community, Doximity empowers clinicians to communicate and collaborate with other care providers. Careers Our careers tools help our members manage their careers from training through retirement.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:56.454702+00:00",
              "published_date": null,
              "source_hash": "381ae0d2a5804464fad11337416da535"
            },
            {
              "url": "",
              "title": "Analyst Ratings For Doximity",
              "snippet": "Doximity Inc is a digital platform for U.S. medical ... relative to peers and suggesting a strong market position. Positive Revenue Trend: Examining Doximity's financials over 3 months reveals ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:59.173784+00:00",
              "published_date": "2024-12-04T09:03:00+00:00",
              "source_hash": "8a8de6f344c719cc8d6b3b69bf903286"
            },
            {
              "url": "",
              "title": "DOXIMITY INVESTOR NOTICE: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties - DOCS",
              "snippet": "On April 1, 2024, Jehoshaphat Research published a report alleging, among other things, that \"Doximity's underlying sales . . . are declining at a negative -3-6% rate, but that this decline has been masked through accelerated revenue recognition.\"",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:59.173891+00:00",
              "published_date": "2024-11-19T22:01:00+00:00",
              "source_hash": "a100b601b789c4788b56077ef5d4621d"
            },
            {
              "url": "",
              "title": "Doximity, Inc. Class A Common Stock (DOCS) Analyst Research",
              "snippet": "This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:59.173924+00:00",
              "published_date": "2024-12-17T17:11:00+00:00",
              "source_hash": "bf312550e87dd3f498511a28ff1dcfdc"
            },
            {
              "url": "",
              "title": "Stephens Initiated Research Coverage for Doximity Inc (DOCS) Stock",
              "snippet": "Doximity Inc (DOCS) stock saw a modest uptick, ending the day at $57.83 which represents a slight increase of $2.65 or 4.80% from the prior close of $55.18. The stock opened at $54.95 and touched a low of $53.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:59.173949+00:00",
              "published_date": "2024-12-23T13:45:00+00:00",
              "source_hash": "9addd61463cb01bfb20283dc91c4ad1e"
            },
            {
              "url": "",
              "title": "Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates",
              "snippet": "Doximity (DOCS) came out with quarterly earnings ... The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Doximity Inc Doximity Inc revenue concentration risks",
              "retrieved_at": "2025-01-06T17:28:59.173972+00:00",
              "published_date": "2024-11-07T17:50:00+00:00",
              "source_hash": "abf9b4bad586d17fc7eaee6d8f43acde"
            },
            {
              "url": "",
              "title": "Doctor Networking Platform Doximity Hit With Investor Lawsuit",
              "snippet": "Doximity Inc. is being sued by a shareholder who alleges the medical networking platform misled shareholders about its profitability. San Francisco-based Doximity downplayed the impact of competition and the platform's reliance on selling additional services like advertising to existing customers to sustain its growth, according to a complaint filed Wednesday in the US District Court for the ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713404+00:00",
              "published_date": null,
              "source_hash": "fbacae589d64bc0bbf0d2d28f24468e0"
            },
            {
              "url": "",
              "title": "Doximity, Inc. Class Action - Robbins LLP",
              "snippet": "Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Doximity, Inc. (NYSE: DOCS) common stock between February 9, 2022 and April 1, 2024. Doximity operates a digital platform that provides connections between, medical information to, and patient ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713559+00:00",
              "published_date": null,
              "source_hash": "2ea8bcb7339dc84a57321fe0b1f5d2d0"
            },
            {
              "url": "",
              "title": "Doximity Sell Rating: User Engagement and Regulatory Risks Impact ...",
              "snippet": "Doximity Sell Rating: User Engagement and Regulatory Risks Impact Growth Outlook. TipRanks. Sep. 20, 2024, 02:47 AM. ... Doximity Inc is a digital platform for U.S. medical professionals. Its ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713573+00:00",
              "published_date": null,
              "source_hash": "38c44057563582a85e46afb2c444b1d2"
            },
            {
              "url": "",
              "title": "DOCS INVESTOR NOTICE: Doximity, Inc. Investors with Substantial Losses ...",
              "snippet": "San Diego, California--(Newsfile Corp. - April 29, 2024) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Doximity, Inc. (NYSE: DOCS) common stock between February 9 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713599+00:00",
              "published_date": null,
              "source_hash": "097a57e4c03467a707613d5d51c011ec"
            },
            {
              "url": "",
              "title": "Class Action Lawsuit Filed on Behalf of Doximity, Inc. - GlobeNewswire",
              "snippet": "ATLANTA, April 19, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Doximity, Inc. (\"Doximity\" or the \"Company\") (NYSE: DOCS).",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713610+00:00",
              "published_date": null,
              "source_hash": "fe09627f957e94b9744cde93d5b1ccdc"
            },
            {
              "url": "",
              "title": "Doximity - Kaskela Law",
              "snippet": "Kaskela Law LLC is investigating Doximity, Inc. (NYSE: DOCS) on behalf of the company's long-term shareholders. Recently a securities fraud complaint was filed against Doximity on behalf of investors who purchased shares of the company's stock between February 9, 2022, and April 1, 2024. According to the complaint, during that time period Doximity and certain [\u2026]",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713624+00:00",
              "published_date": null,
              "source_hash": "ce3215f1434cbfeb91348bdcd1e9cf26"
            },
            {
              "url": "",
              "title": "DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP ...",
              "snippet": "On this news, the price of Doximity common stock declined $7.49 per share, or nearly 23%, from a close of $32.79 per share on August 8, 2023, to close at $25.30 per share on August 9, 2023.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:00.713643+00:00",
              "published_date": null,
              "source_hash": "7b2de90cd603912c9b4a5efafee62c84"
            },
            {
              "url": "",
              "title": "Doximity, Inc. (DOCS)",
              "snippet": "Sustainalytics' Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company's operations. Controversies ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:04.144881+00:00",
              "published_date": "2024-12-21T01:00:00+00:00",
              "source_hash": "38645f7fe918591a36878f6cffa3ff5d"
            },
            {
              "url": "",
              "title": "Doximity Reaches Analyst Target Price",
              "snippet": "In recent trading, shares of Doximity Inc (Symbol: DOCS) have crossed above the average analyst 12-month target price of $53.50, changing hands for $54.20/share. When a stock reaches the target an ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Doximity Inc Doximity Inc user engagement controversies",
              "retrieved_at": "2025-01-06T17:29:04.145098+00:00",
              "published_date": "2024-12-04T11:55:00+00:00",
              "source_hash": "d513a7c1f3fca1be91388219b8fe15c1"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Doximity Inc data privacy lawsuits",
              "rationale": "Investigate legal challenges related to data security and HIPAA compliance",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Doximity Inc revenue concentration risks",
              "rationale": "Assess potential financial vulnerabilities due to reliance on pharmaceutical advertising",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Doximity Inc user engagement controversies",
              "rationale": "Explore concerns about declining platform activity among healthcare professionals",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T10:29:21.633143",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}